SecBot SecBot
8-K ·Filed Oct 9, 2026

XRAY

DENTSPLY SIRONA Inc.
NEUTRAL
Impact 4/10
Horizonmonths Processed18d 7h ago SEC0000818479-26-000278
8-K material event: Items 1.01
Actionable Insight • Neutral

The covenant relief and EBITDA addback suggest management expects elevated leverage through year-end 2026. Monitor the Q3 2026 earnings release for the actual leverage ratio and details on the Specified Addback Matter. The next quarterly noteholder call (per Section 7.5) should provide updated projections through September 2027.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+5d
XRAY ▼ -1.29% at T+5d
NEUTRAL call -1.29% · α vs SPY +0.20% · entry $8.53 → $8.42
Next anchor: T+20d in 9d
Latest observation: T+9 +10.15% FF3 residual α
Entry = T+0 close
Oct 9, 2026
via day close
T+1d
-0.29%
call -0.29% · α -0.28%
$8.51
settled 16d ago
T+5d
-1.29%
call -1.29% · α +0.20%
$8.42
settled 12d ago
T+20d
Pending
in 9d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Dentsply Sirona entered into a Third Amendment to its $700M revolving credit facility and a Fifth Amendment to its 2016 Note Purchase Agreement, both dated September 30, 2026. The amendments relax financial covenants (Total Leverage Ratio and Senior Leverage Ratio) for fiscal quarters ending September 30, 2026 and December 31, 2026, and add a $100M EBITDA addback for a 'Specified Addback Matter' in Q3 and Q4 2026. The note amendment also increases the leverage-based interest step-up thresholds and caps the total step-up at 2.00% (from 1.75%). These changes provide the company with additional covenant headroom during a period of elevated leverage.

Key Facts

  • Third Amendment to $700M revolving credit facility dated September 30, 2026
  • Fifth Amendment to 2016 Note Purchase Agreement dated September 30, 2026
  • Total Leverage Ratio covenant relaxed to 4.25x for Q3 and Q4 2026 (from 4.00x)
  • Senior Leverage Ratio covenant relaxed to 3.25x for Q3 and Q4 2026 (from 3.00x)
  • New $100M EBITDA addback for 'Specified Addback Matter' in Q3 and Q4 2026
  • Leverage step-up thresholds increased: 0.75% for leverage >=4.00x, 0.50% for 3.75x-4.00x
  • Total interest rate step-up cap increased to 2.00% per annum (from 1.75%)
  • Noteholders received a 0.25% amendment fee
  • Restricted payments limited to $25M per quarter during Specified Period
  • Lien and debt baskets tied to 5% of Consolidated Net Worth (previously a fixed dollar amount)

Financial Impact

Covenant relaxation provides ~0.25x additional leverage headroom for Q3/Q4 2026; $100M EBITDA addback for Specified Addback Matter; noteholders received 0.25% amendment fee on principal

Total Leverage RatioSenior Leverage RatioEBITDAinterest rate step-up

Risk Factors

  • Elevated leverage may persist beyond the Specified Period if restructuring savings are delayed
  • The $100M EBITDA addback for Specified Addback Matter could mask underlying operational weakness
  • Increased interest step-up cap (2.00%) adds cost if leverage remains high

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000818479-26-000278
Exhibit: ex43-fifthamendmenttonot.htm0000818479-26-000278
12 reports for XRAY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XRAY — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
Press Release
NEUTRAL ★ 1/10
$9.08awaiting T+60—$9.35 (+2.97%)
Oct 9, 2026
18d ago
8-K
NEUTRAL ★ 4/10
$8.53awaiting T+60—$9.35 (+9.61%)
Sep 10, 2026
6w ago
Institutional Cluster
MIXED ★ 5/10
$10.50awaiting T+60—$9.35 (−10.95%)
Jun 16, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$10.03 $10.46▲ +4.29%▲ +1.14%$9.35 (−6.78%)
Jun 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$10.45 $10.50▲ +0.48%▼ −0.52%$9.35 (−10.53%)
Jun 11, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$10.14 $11.38▲ +12.23%▲ +7.83%$9.35 (−7.79%)
May 5, 2026
25w ago
8-K
BEARISH ★ 6/10
$11.14 $13.37▼ −20.02%▼ −17.96%$9.35 (+16.07%)
May 5, 2026
25w ago
Press Release
MIXED ★ 5/10
$11.14 $13.37▲ +20.02%▲ +17.96%$9.35 (−16.07%)
Apr 22, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$11.90 $13.46▲ +13.11%▲ +8.09%$9.35 (−21.43%)
Mar 9, 2026
33w ago
Press Release
BULLISH ★ 7/10
$12.80 $9.83▼ −23.20%▼ −35.19%$9.35 (−26.95%)
Showing 10 of 12

US Market Status

Market Closed — Opens in 9h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 9, 2026